Dataset opportunity
Virtuososurgical — 医疗影像数据集机会
Virtuososurgical 持有的中等规模医疗影像数据集,可用于诊断人工智能和计算机视觉。
Score
70
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球诊断人工智能市场规模在 2025 年为 70.3 亿美元,预计将以 41.27% 的复合年增长率增长。
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-11-10
Virtuoso robot wins FDA nod for bladder tumor removal
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 📣Press / announcement
突破性同心管机器人技术的开发
source ↗
Profile
Dataset profile
Type
医疗影像数据集
Modality
图像
Sector
医疗保健
Volume
中等
Freshness
实时
Rarity
高(专有)
Accessibility
受限
Legal
公司所有 — GDPR 敏感(个人身份信息审查)
Buyer persona
医疗人工智能与诊断影像公司
Virtuososurgical 持有一个独特的医疗影像数据集,该数据集由丰富的 `image_collection`(手术视频)组成,并辅以手术器械的 `iot_data` 和相关的 `medical_records`。这种多模态集合提供了手术过程的全面视图,使其在训练和验证旨在分析复杂、真实手术场景和预测患者结果的高性能诊断人工智能模型方面具有极高的价值。
全球诊断人工智能市场正经历爆炸式增长,2025 年市场规模为70.3 亿美元,预计将以41.27% 的复合年增长率扩张。巨大的需求使得稀有、高质量的手术视频数据成为人工智能开发者的关键资产。尽管由于严格的 HIPAA/FDA 法规和共享的临床数据所有权存在访问复杂性,但该数据集无与伦比的深度对于创建下一代人工智能工具至关重要,值得为获取访问权限进行谈判。⚠ 尽职调查(有价值的数据,可协商访问):受严格的医疗数据法规(HIPAA/FDA)约束;数据涉及敏感的手术视频和患者结果;临床数据的所有权可能与试验医院共享 · 公司:独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据表明 Virtuososurgical 拥有独特、专有的数据集,结合了高清手术视频、同步的机器人传感器数据和详细的手术记录。这种多模态集合是医疗人工智能公司开发下一代诊断人工智能和手术分析平台的关键资产。在全球诊断人工智能市场预计每年增长 40% 以上的情况下,这种丰富、情境化的数据对于实现临床级准确性和竞争优势至关重要。
See dimension details ↓- Dataset Specificity90
主导的“医疗记录”,医疗保健行业,3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式传输
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
人工智能买家需求异常高,这得益于市场的快速扩张和预计 41.27% 的复合年增长率,从而产生了对专业手术数据以训练先进诊断模型的迫切需求。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
个人身份信息/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度,独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型,3 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
所有权=公司所有,许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 个数据需求信号(1 种类型)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高,1 个近期外部信号 — 超出已货币化范围的专有数据
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — 这家商业前医疗设备公司是理想目标,因为其核心业务是开发物理机器人手术系统,该系统本身会产生有价值的、未货币化的数据(手术视频、遥测数据)作为副产品。问题:根据最新的财务申报,该公司目前处于亏损状态,首款产品计划于 2027 年推出;该公司目前专注于获得 FDA 批准和商业化其硬件,因此数据货币化可能不是他们当前的优先事项。
- Deep Qualification80
✓ 通过 — Virtuoso Surgical 是一家医疗设备制造商,而不是数据销售商。它拥有从获得近期 FDA 批准的临床试验中获得的独特且有价值的数据集。然而,该公司的商业模式是销售设备,并且这些敏感临床数据的所有权和再利用权非常复杂,并受到 HIPAA 的严格监管,这使得直接获取用于无关的人工智能训练极具挑战性。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
这些证据指向了一系列机器人传感器数据,包括运动和力反馈日志,这对于训练手术机器人和触觉系统的人工智能至关重要。
Image collection
该公司拥有来自专业泌尿外科、妇科和胸外科手术的高清内窥镜视频,这是训练诊断人工智能计算机视觉模型的核心资产。
Medical records / imaging
这些数据包括详细的手术元数据,记录了手术步骤和器械交互,为开发情境感知手术分析提供了必要的地面真实标签。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Virtuososurgical Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in diagnostics market size was valued at USD 7.03 billion in 2025, projected to grow at a CAGR of 41.27% (source: Fortune Business Insights). Investment score 70.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Rocklandcapital — 维护日志数据集机会
View opportunity →工业Nordsol — 维护日志数据集机会
View opportunity →其他Gsi — 工业运营数据集机会
View opportunity →